Accelerate Diagnostics Company Profile (NASDAQ:AXDX)

About Accelerate Diagnostics

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that improve patient outcomes and lower healthcare costs through the diagnosis of serious infections. The Company's technology platform is built to address these challenges by delivering testing of infectious pathogens in various patient sample types. The Company is focused on the development of a rapid diagnostic platform, the Accelerate ID/AST System (ID/AST System or Accelerate ID/AST System), intended for the diagnosis of infectious pathogens. The ID/AST System utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. The ID/AST System features walk-away automation and consists of a fixed instrument and single-use test kit.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Laboratories & Research
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: AXDX
CUSIP:

Key Metrics:

Previous Close: $27.01
50 Day Moving Average: $23.76
200 Day Moving Average: $17.03
52-Week Range: $10.29 - $28.50
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -19.70
P/E Growth: -0.69
Market Cap: $1.39B
Outstanding Shares: 51,228,000
Beta: 1.19

Profitability:

Net Margins: -19,501.35%
Return on Equity: -58.23%
Return on Assets: -55.13%

Debt:

Current Ratio: 23.58%
Quick Ratio: 23.58%

Additional Links:

Companies Related to Accelerate Diagnostics:

Consensus Ratings for Accelerate Diagnostics (NASDAQ:AXDX) (?)

Ratings Breakdown:	4 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$25.33 (6.79% downside)

Analysts' Ratings History for Accelerate Diagnostics (NASDAQ:AXDX)

Show:

Date	Firm	Action	Rating	Price Target
8/25/2016	BTIG Research	Upgrade	Neutral -> Buy
8/9/2016	JPMorgan Chase & Co.	Boost Price Target	Overweight	$17.00 -> $25.00
5/16/2016	Piper Jaffray Cos.	Reiterated Rating	Overweight	$25.00
1/29/2016	William Blair	Reiterated Rating	Buy

(Data available from 9/27/2014 forward)

Earnings History for Accelerate Diagnostics (NASDAQ:AXDX)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Accelerate Diagnostics (NASDAQ:AXDX)

Current Year EPS Consensus Estimate: $-1.33 EPS
Next Year EPS Consensus Estimate: $-1.38 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q2 2016	1	($0.31)	($0.31)	($0.31)
Q3 2016	1	($0.32)	($0.32)	($0.32)
Q4 2016	1	($0.33)	($0.33)	($0.33)
Q1 2017	1	($0.33)	($0.33)	($0.33)
Q2 2017	1	($0.33)	($0.33)	($0.33)
Q3 2017	1	($0.31)	($0.31)	($0.31)
Q4 2017	1	($0.31)	($0.31)	($0.31)

(Data provided by Zacks Investment Research)

Dividend History for Accelerate Diagnostics (NASDAQ:AXDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Accelerate Diagnostics (NASDAQ:AXDX)

Insider Ownership Percentage: 51.40%
Institutional Ownership Percentage: 35.62%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/30/2016	Jack W Schuler	Director	Buy	90,147	$13.95	$1,257,550.65
6/14/2016	Jack W Schuler	Director	Buy	14,033	$13.67	$191,831.11
6/13/2016	Jack W Schuler	Director	Buy	15,967	$13.70	$218,747.90
6/10/2016	Jack W Schuler	Director	Buy	88,316	$14.69	$1,297,362.04
6/9/2016	Jack W Schuler	Director	Buy	101,272	$14.14	$1,431,986.08
5/20/2016	Jack W Schuler	Director	Buy	4,270	$11.04	$47,140.80
5/17/2016	Jack W Schuler	Director	Buy	10,000	$11.45	$114,500.00
5/16/2016	Jack W Schuler	Director	Buy	11,511	$11.91	$137,096.01
5/13/2016	Jack W Schuler	Director	Buy	20,000	$12.45	$249,000.00
2/9/2016	Jack W Schuler	Director	Buy	600,000	$11.86	$7,116,000.00
2/8/2016	Jack W Schuler	Director	Buy	20,000	$12.32	$246,400.00
2/5/2016	Jack W Schuler	Director	Buy	7,308	$12.65	$92,446.20
2/4/2016	Jack W Schuler	Director	Buy	10,000	$12.98	$129,800.00
2/3/2016	Jack W Schuler	Director	Buy	50,100	$13.09	$655,809.00
2/2/2016	Jack W Schuler	Director	Buy	20,000	$13.46	$269,200.00
1/21/2016	Jack W Schuler	Director	Buy	10,000	$15.02	$150,200.00
12/10/2015	Larry N Feinberg	Major Shareholder	Buy	117,647	$17.00	$1,999,999.00
11/5/2015	Jack W Schuler	Director	Buy	11,899	$16.81	$200,022.19
11/4/2015	Jack W Schuler	Director	Buy	52,837	$16.81	$888,189.97
10/22/2015	Jack W Schuler	Director	Buy	2,160	$15.82	$34,171.20
9/29/2015	Brink Frank Jm Ten	Director	Buy	9,800	$15.24	$149,352.00
8/26/2015	Jack W Schuler	Director	Buy	10,000	$17.81	$178,100.00
8/25/2015	Jack W Schuler	Director	Buy	10,000	$18.56	$185,600.00
4/17/2015	Jack W Schuler	Director	Buy	11,000	$21.94	$241,340.00
3/19/2015	Matthew Strobeck	Director	Buy	2,000	$22.04	$44,080.00
3/9/2015	Jack W Schuler	Director	Buy	22,584	$17.18	$387,993.12
1/5/2015	Jack W Schuler	Director	Buy	18,000	$18.93	$340,740.00
9/22/2014	Jack W Schuler	Director	Buy	2,588	$16.44	$42,546.72
9/19/2014	Jack W Schuler	Director	Buy	32,411	$16.67	$540,291.37
8/21/2014	Jack W Schuler	Director	Buy	2,900	$16.79	$48,691.00
8/5/2014	Larry N Feinberg	Major Shareholder	Buy	11,835	$15.92	$188,413.20
8/5/2014	Matthew Strobeck	Director	Buy	20,000	$16.70	$334,000.00
8/4/2014	Matthew Strobeck	Director	Buy	20,000	$16.70	$334,000.00
7/16/2014	Larry N Feinberg	Major Shareholder	Buy	20,000	$21.54	$430,800.00
7/1/2014	Jack W Schuler	Director	Buy	8,698	$25.70	$223,538.60
6/30/2014	Jack W Schuler	Director	Buy	10,000	$26.09	$260,900.00
6/30/2014	Larry N Feinberg	Major Shareholder	Buy	20,000	$25.72	$514,400.00
5/12/2014	Larry N Feinberg	Major Shareholder	Buy	297,618	$16.80	$4,999,982.40
2/5/2014	Larry N Feinberg	Major Shareholder	Buy	8,554	$24.78	$211,968.12
1/27/2014	Larry N Feinberg	Major Shareholder	Buy	16,307	$13.09	$213,458.63
12/31/2013	Larry N Feinberg	Major Shareholder	Buy	84,081	$12.29	$1,033,355.49
10/30/2013	Larry N Feinberg	Major Shareholder	Buy	10,000	$12.95	$129,500.00
8/30/2013	Larry N Feinberg	Major Shareholder	Buy	16,001	$9.76	$156,169.76
8/28/2013	Larry N Feinberg	Major Shareholder	Buy	158,445	$9.80	$1,552,761.00
8/16/2013	Jack W Schuler	Director	Buy	78,494	$7.88	$618,532.72
8/14/2013	Jack W Schuler	Director	Buy	413,090	$8.04	$3,321,243.60
8/14/2013	Larry N Feinberg	Major Shareholder	Buy	36,814	$7.24	$266,533.36
8/9/2013	Larry N Feinberg	Major Shareholder	Buy	35,168	$7.30	$256,726.40
6/21/2013	Larry N Feinberg	Major Shareholder	Buy	114,250	$8.00	$914,000.00
6/12/2013	Larry N Feinberg	Major Shareholder	Buy	7,175	$8.41	$60,341.75
6/7/2013	Larry N Feinberg	Major Shareholder	Buy	45,508	$8.33	$379,081.64

(Data available from 1/1/2013 forward)

Latest Headlines for Accelerate Diagnostics (NASDAQ:AXDX)

Date	Headline
	ETF’s with exposure to Accelerate Diagnostics, Inc. : September 19, 2016 (NASDAQ:AXDX) www.capitalcube.com - September 19 at 4:39 PM
	Accelerate Diagnostics (AXDX) Enters Overbought Territory (NASDAQ:AXDX) finance.yahoo.com - September 16 at 3:41 PM
	Is Buying Accelerate Diagnostics Inc Here a Winning Strategy? - Chester News (NASDAQ:AXDX) www.chesterindependent.com - September 15 at 12:35 PM
	4 Breakout Stocks to Watch (NASDAQ:AXDX) www.thestreet.com - September 13 at 8:34 AM
	Consensus Analyst Opinions for: Summit Materials, Inc. (NYSE:SUM) , Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Wall Street Times (press release) (NASDAQ:AXDX) www.wallstreetnews24.com - September 12 at 8:29 AM
	Stock Gapping Higher Pre-Market: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Post News (NASDAQ:AXDX) www.kentuckypostnews.com - September 8 at 3:39 PM
	Accelerate Diagnostics Inc. (NASDAQ: AXDX) Upgraded to Hold - BNB Daily (blog) (NASDAQ:AXDX) www.baseball-news-blog.com - September 7 at 11:53 AM
	ETF’s with exposure to Accelerate Diagnostics, Inc. : September 6, 2016 (NASDAQ:AXDX) www.capitalcube.com - September 6 at 3:45 PM
	ETF’s with exposure to Accelerate Diagnostics, Inc. : August 19, 2016 (NASDAQ:AXDX) www.capitalcube.com - August 19 at 4:21 PM
	ETF’s with exposure to Accelerate Diagnostics, Inc. : August 19, 2016 (NASDAQ:AXDX) www.capitalcube.com - August 19 at 4:21 PM
	Notable Tuesday Option Activity: AXDX, LE, ENR (NASDAQ:AXDX) www.stockoptionschannel.com - August 16 at 3:46 PM
	ACCELERATE DIAGNOSTICS, INC Financials (NASDAQ:AXDX) finance.yahoo.com - August 16 at 3:46 PM
	ACCELERATE DIAGNOSTICS, INC Financials (NASDAQ:AXDX) finance.yahoo.com - August 16 at 3:46 PM
	Accelerate Diagnostics, Inc. :AXDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:AXDX) www.capitalcube.com - August 12 at 12:20 PM
	Chartist Inc Ca buys $1279969 stake in Accelerate Diagnostics Inc (AXDX) - Trade Calls (NASDAQ:AXDX) www.tradecalls.org - August 10 at 8:28 AM
	Accelerate Diagnostics Inc. (NASDAQ: AXDX) Target price raised at JPMorgan - BNB Daily (blog) (NASDAQ:AXDX) www.baseball-news-blog.com - August 10 at 8:28 AM
	Accelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q2 2016 Results - Earnings Call Transcript (NASDAQ:AXDX) seekingalpha.com - August 9 at 12:33 PM
	Chartist Inc Ca buys $1,279,969 stake in Accelerate Diagnostics Inc (AXDX) (NASDAQ:AXDX) www.tradecalls.org - August 9 at 12:33 PM
	Accelerate Diagnostics (AXDX) Regulatory Matters in Order; BTIG Affirms at 'Buy' (NASDAQ:AXDX) www.streetinsider.com - August 9 at 12:33 PM
	Accelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:AXDX) seekingalpha.com - August 8 at 9:07 PM
	Accelerate Diagnostics reports 2Q loss (NASDAQ:AXDX) sg.finance.yahoo.com - August 8 at 9:07 PM
	Q2 2016 Accelerate Diagnostics Inc Earnings Release - After Market Close (NASDAQ:AXDX) biz.yahoo.com - August 8 at 8:29 AM
	Yahoo Finance and AYDX (NASDAQ:AXDX) www.goerie.com - August 3 at 12:20 PM
	Berko: Ditch Yahoo Finance for stock advice; buy AXDX (NASDAQ:AXDX) www.columbian.com - July 31 at 3:40 PM
	Taking Stock: Loyal users find Yahoo Finance has been hijacked by an inferior Yaphooey Finance (NASDAQ:AXDX) newsok.com - July 31 at 8:37 AM
	ETF’s with exposure to Accelerate Diagnostics, Inc. : July 26, 2016 (NASDAQ:AXDX) www.capitalcube.com - July 26 at 11:45 AM
	Accelerate Diagnostics Inc. : Accelerate Diagnostics to Report Second-Quarter 2016 Results on August 8 - The Wall Street Transcript (NASDAQ:AXDX) www.twst.com - July 22 at 11:52 AM
	Accelerate Diagnostics to Report Second-Quarter 2016 Results on August 8 (NASDAQ:AXDX) www.publicnow.com - July 22 at 8:38 AM
	Accelerate Diagnostics Incorporated (NASDAQ:AXDX) Short Interest Increased By 2.3% - Consumer Eagle (NASDAQ:AXDX) www.consumereagle.com - July 21 at 9:35 AM
	Share Performance Summary for: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph (NASDAQ:AXDX) presstelegraph.com - July 19 at 3:42 PM
	Today's Hot List: Accelerate Diagnostics, Inc. (NASDAQ:AXDX), Chanticleer (NASDAQ:HOTR), Bluerock Residential ... - KC Register (NASDAQ:AXDX) www.kcregister.com - July 18 at 3:45 PM
	Accelerate Diagnostics Inc Stock Faces Higher Risks Forward After Forming Bearish Double Bottom - Press Telegraph (NASDAQ:AXDX) presstelegraph.com - July 18 at 3:45 PM
	Stock in Positive Territory for the Quarter: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Engelwood Daily (NASDAQ:AXDX) www.engelwooddaily.com - July 17 at 3:36 PM
	Accelerate Diagnostics Inc Realized Volatility Hits Extreme Level - CML News (NASDAQ:AXDX) news.cmlviz.com - July 16 at 10:04 AM
	4 Stocks To Watch: ACIA, AXDX, LCI, XNCR (NASDAQ:AXDX) www.investing.com - July 15 at 2:17 PM
	Accelerate Diagnostics Inc. (AXDX) is Trading Higher on Unusual Volume for July 12 - Equities.com (NASDAQ:AXDX) www.equities.com - July 14 at 12:36 PM
	Accelerate Diagnostics Incorporated (NASDAQ:AXDX) Shorted Shares Increased By 5.45% - Consumer Eagle (NASDAQ:AXDX) www.consumereagle.com - July 13 at 11:49 AM
	ACCELERATE DIAGNOSTICS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:AXDX) biz.yahoo.com - July 13 at 6:02 AM
	Stock on the Rise for the Quarter: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Engelwood Daily (NASDAQ:AXDX) www.engelwooddaily.com - July 11 at 8:30 AM
	Stock Performance Rundown on: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph (NASDAQ:AXDX) presstelegraph.com - July 11 at 8:30 AM
	Accelerate Diagnostics Submits De Novo Request to FDA for Accelerate Pheno™ System and Accelerate PhenoTest™ BC kit (NASDAQ:AXDX) www.publicnow.com - July 11 at 5:23 AM
	5:12 am Accelerate Diagnostics submits De Novo request for its Accelerate Pheno system and Accelerate PhenoTest for Evaluation of Automatic Class III Designation to the FDA (NASDAQ:AXDX) finance.yahoo.com - July 11 at 5:12 AM
	Accelerate Diagnostics Incorporated (NASDAQ:AXDX) Sellers Increased By 5.45% Their Shorts - Engelwood Daily (NASDAQ:AXDX) www.engelwooddaily.com - July 10 at 8:27 AM
	Accelerate Diagnostics Inc (NASDAQ:AXDX) Institutional Investors Sentiment Change - Engelwood Daily (NASDAQ:AXDX) www.engelwooddaily.com - July 8 at 8:50 PM
	Insiders Increasing Positions in: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph (NASDAQ:AXDX) presstelegraph.com - July 7 at 3:43 PM
	Shares Providing Results This Month for Investors: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Telanagana Press (NASDAQ:AXDX) telanaganapress.com - July 6 at 8:29 AM
	Accelerate Diagnostics Inc. (AXDX) Jumps 12.72% on July 04 - Equities.com (NASDAQ:AXDX) www.equities.com - July 6 at 8:29 AM
	Share Performance Recap for: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph (NASDAQ:AXDX) presstelegraph.com - July 5 at 3:40 PM
	Broker Outlook For The Week Ahead Accelerate Diagnostics, Inc. (AXDX) - Fiscal Standard (NASDAQ:AXDX) www.fiscalstandard.com - July 4 at 3:39 PM
	Friday’s Stock Recap: The Big Movers (NASDAQ:AXDX) www.fxpips.com - July 4 at 8:33 AM